Inventor · disambiguated record
Bruce Connop
Also filed as: CONNOP BRUCE P · CONNOP BRUCE PETER
5 granted patents·6 pending applications·90 citations·filing 1998–2019
80Inventor score
Top patents by PatentIndex Score
11 records- 0181US5981168AMethod and composition for modulating amyloidosisUNIV BRITISH COLUMBIA·Filed 1998·Granted Nov 9, 1999·45 cites·69 claims
- 0277US6472145B2Method and composition for modulating amyloidosisUNIV BRITISH COLUMBIA·Filed 2001·Granted Oct 29, 2002·10 cites·64 claims
- 0376US6221667B1Method and composition for modulating amyloidosisUNIV BRITISH COLUMBIA·Filed 1999·Granted Apr 24, 2001·34 cites·24 claims
- 0443US6830913B1ABCB9 transporter and uses thereofACTIVE PASS PHARMACEUTICALS IN·Filed 2000·Granted Dec 14, 2004·1 cites·15 claims
- 0538US2004235102A1Novel ABCB9 transporter and uses thereofACTIVE PASS PHARMACEUTICALS IN·Filed 2004·Application pending·0 cites
- 0637US2002192821A1Increased functional activity and/or expression of ABC transporters protects against the loss of dopamine neurons associated with Parkinson's diseaseACTIVE PASS PHARMACEUTICALS IN·Filed 2002·Application pending·0 cites
- 0736US12441776B2Oxyntomodulin peptide analog formulationsEIRGEN PHARMA LTD·Filed 2019·Granted Oct 14, 2025·0 cites·20 claims
- 0836US2002123106A1Novel ABCA9 transporter and uses thereofACTIVE PASS PHARMACEUTICALS IN·Filed 2002·Application pending·0 cites
- 0933US2003191144A1Compounds, compositions and methods for modulating beta-amyloid productionACTIVE PASS PHARMACEUTICALS IN·Filed 2002·Application pending·0 cites
- 1032US2003125338A1Compounds, compositions and methods for modulating beta-amyloid productionACTIVE PASS PHARMACEUTICALS IN·Filed 2002·Application pending·0 cites
- 1129US2002169137A1Regulation of amyloid precursor protein expression by modification of ABC transporter expression or activityACTIVE PASS PHARMACEUTICALS IN·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bruce Connop files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →